PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NuLiv Science

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NuLiv Science to Attend SupplySide West 2013 - Nuliv Science, a research focused ingredient supplier, today announced they will be in attendance at the SupplySide West 2013 Expo held at the The Venetian Hotel and Casino in Las Vegas, Nevada
NuLiv Science to Attend SupplySide West 2013

 

NewswireToday - /newswire/ - Walnut, CA, United States, 2013/10/22 - Nuliv Science, a research focused ingredient supplier, today announced they will be in attendance at the SupplySide West 2013 Expo held at the The Venetian Hotel and Casino in Las Vegas, Nevada.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The two-day event will showcase some of the industry’s most prominent business vendors, ingredient suppliers and industry experts. The expo will feature thousands of dietary and nutritional supplement vendors from around the world along with an estimated, 1,700 booths offering more than 10,000 ingredients and services.

SupplySide West brings suppliers and buyers to one place to drive the dietary supplement marketplace to showcase the new and innovative products and ingredients that will break through the market. Key professionals and thought leaders from executive management, quality assurance, research & development and marketing teams will be in attendance at the prolific expo.

“We are excited to be attending the world’s largest ingredient and supply expo, Supplyside West.” Michael Wang, President of Nuliv Science,“Supplyside West is a great opportunity for doctors, experts, industry professionals and businesses to really understand and be exposed to new and cutting-edge products and ingredients.”

Nuliv Science (nulivusa.com) will be distributing samples as well as reaching out to industry experts and professionals and educating them on their groundbreaking research and products including AstraGin, the ultimate enhancement and nutrient absorption catalyst, and ActiGin, the ultimate endurance and sports intensity product.

Nuliv Science is a research and development company that prides itself as being a recognized leader for development of evidence based health therapy interventions and a commercial platform that facilitates nutraceutical business.

PR Contact: Richard Wang, MPH, Nuliv Science USA Inc.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NuLiv Science

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


NuLiv Science to Attend SupplySide West 2013

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Andrew Gonzales - NuLivScience.com 
909-594-3188 andrew[.]nulivusa.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NuLiv Science securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NuLiv Science / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)